About YMSLABS
YMSLABS is a Chemicals & Materials company. Chemical entities development and pharmaceutical intermediates in India. The company has 55 employees. Its Indian entity Yms Laboratories Private Limited reported revenue of βΉ36.29 Cr. YMSLABS offers products and services including Pyridine Derivatives and Pharmaceutical Bulk Drug Intermediates. Its focus areas include Chemicals, Pharmaceutical Manufacturing, Bulk Drug Intermediates and Chemical Scaling.
Company details
YMS Laboratories Pvt. Ltd. is noted for its emphasis on the development of new chemical entities, where optimization and scaling processes from gram to multi-ton scales are undertaken. The company was established in 2011 under the Indian Companies Act, 1956, with its registered office located in Hyderabad, Telangana, India, and manufacturing facilities positioned in Raichur, Karnataka, India. Research and development efforts are supported by dedicated centers, focusing on pyridine derivatives and pharmaceutical bulk drug intermediates to meet industry demands. Operational activities are managed through B2B models, ensuring compliance and efficiency in chemical production.
- Employees 55
- SectorsChemicals & Materials
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website ymslabs.com
- Legal Name Y M S Laboratories Pvt. Ltd
- Date of Incorporation 07 Mar, 2011
- Jurisdiction Hyderabad, Telangana, India
- Indian entity revenue₹36.29 Cr
FY 2024 · +34% YoY
- Indian entity net profit₹2.09 Cr
FY 2024 · 6% margin
- Indian entity EBITDA₹4.62 Cr
FY 2024 · 13% margin
- Employee Count55
Associated legal entities of YMSLABS
YMSLABS operates through Yms Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Yms Laboratories Private Limited CIN U24233TG2011PTC073080 | Active | 07 Mar 2011 | Hyderabad, Telangana | ₹36.3 Cr | 55 | 2 | View details |
Products & Services of YMSLABS
YMSLABS offers a comprehensive portfolio of products and services, including Pyridine Derivatives and Pharmaceutical Bulk Drug Intermediates.
Pyridine derivatives are developed and scaled for pharmaceutical uses
Pharmaceutical bulk drug intermediates are optimized and manufactured for drug production processes
Board of directors of Yms Laboratories Private Limited (YMSLABS)
Yms Laboratories Private Limited is the primary company behind YMSLABS. The board of Yms Laboratories Private Limited currently have 2 directors; the longest-serving is Penumatsa Sivasai Dattatreyavarma, appointed in 2013. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Penumatsa Sivasai Dattatreyavarma DIN 06593337 | Director | 11 Nov 2013 | 13 yrs | Yms Laboratories Private Limited |
| Bangar Raju Kanumuri DIN 06758960 | Director | 11 Nov 2013 | 13 yrs | Yms Laboratories Private Limited |
Financials of YMSLABS
Figures of Yms Laboratories Private Limited, the primary company behind YMSLABS, for FY 2024. Revenue was ₹36.29 Cr (+34% year on year). Net profit was ₹2.09 Cr (6% margin). EBITDA was ₹4.62 Cr (13% margin). Revenue has grown at a compounded annual rate of +76% over three years and +34% over five years.
- ₹36.29 CrRevenue · FY 2024 · +34% YoY
- ₹2.09 CrNet profit · 6% margin
- ₹4.62 CrEBITDA · 13% margin
- ₹4.61 CrPaid-up capital
- 55Employees (provident fund records)
- +76%Revenue CAGR, 3 years
- +34%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Yms Laboratories Private Limited are on its company page.
Detailed financial statements for YMSLABS
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about YMSLABS
YMSLABS has 55 employees.
The primary company behind YMSLABS, Yms Laboratories Private Limited, reported revenue of βΉ36.29 Cr for FY 2024, up 34% year on year.
YMS Laboratories Pvt. Ltd. is noted for its emphasis on the development of new chemical entities, where optimization and scaling processes from gram to multi-ton scales are undertaken. The company was established in 2011 under the Indian Companies Act, 1956, with its registered office located in Hyderabad, Telangana, India, and manufacturing facilities positioned in Raichur, Karnataka, India. Research and development efforts are supported by dedicated centers, focusing on pyridine derivatives and pharmaceutical bulk drug intermediates to meet industry demands. Operational activities are managed through B2B models, ensuring compliance and efficiency in chemical production.
YMSLABS offers Pyridine Derivatives and Pharmaceutical Bulk Drug Intermediates.
YMSLABS operates through Yms Laboratories Private Limited.
The legal entities of YMSLABS currently have 2 directors, including Penumatsa Sivasai Dattatreyavarma, Bangar Raju Kanumuri.
